İçeriğe geç
akaturk Akademik ölçüm
Giriş yap Kayıt ol

Akademisyen

ERDAL SAĞ

DOÇENT

HACETTEPE ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ

Araştırma konuları OpenAlex
Akademik özet YÖKSİS ve OpenAlex ayrı sayılır.
Makale 92
YÖKSİS92 OpenAlex0
Proje 9
Kitap 9
Bildiri 65

Atıf etkisi

OpenAlex YÖKSİS makalelerinden OpenAlex’te eşleşen: 6
h-indeks 5 Türkiye yüzdelik dilimi: 66 Üniversitesinde h-indekse göre 444. / 1.431
i10-indeks
3
Toplam atıf
55
Türkiye’de üst %42
Makale başına
9,2
FWCI
0,59
1,00 = dünya ortalaması
Dünyada üst %1
0
Dünyada üst %10
0

En çok atıf alan makaleleri

  1. Hyperthyroidism After Allogeneic Hematopoietic Stem Cell Transplantation A Report of Four Cases 2015 16 atıf
  2. Inflammatory milieu of muscle biopsies in juvenile dermatomyositis 2021 16 atıf
  3. A new biopsychosocial and clinical questionnaire to assess juvenile idiopathic arthritis: JAB-Q 2018 10 atıf

h-indeks ve atıflar, bu akademisyenin YÖKSİS makalelerinden OpenAlex’te eşleşenlerin atıf sayılarından hesaplanır (Google Scholar, WoS veya Scopus değildir). Eşleşmeyen makalelerin atıfı dahil değildir.

Alan sıralaması

YÖKSİS ?

Dizin çeyrekleri

?
Scopus (SJR) 89
  • Q1 52
  • Q2 30
  • Q3 7
  • Q4 0
WoS (JCR) 88
  • Q1 42
  • Q2 24
  • Q3 13
  • Q4 9
TR Index TR Index

4 makale

OpenAlex atıf yüzdelik
  • Üst %1 0
  • Üst %10 0
  • Ort. 61.8%
  • n 6
Diğer sayımlar

Scopus (SJR)

  • Özet hariç 88 Q1 51 Q2 30 Q3 7
  • YÖKSİS satırı 92

WoS (JCR)

  • Özet hariç 87 Q1 41 Q2 24 Q3 13 Q4 9
  • YÖKSİS satırı 91

TR Index

  • YÖKSİS satırı 5 makale

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Yayını olan dergiler

38 dergi
Scopus (SJR)
Q1 52 Q2 30 Q3 7 Q4 0
WoS (JCR)
Q1 42 Q2 24 Q3 13 Q4 9
TR Index
4 makale

Makale listesi

  1. 2025 Efficacy and safety of treatments in familial Mediterranean fever and its complications: a systematic review informing the EULAR/PReS recommendations for familial Mediterranean fever Annals of the Rheumatic Diseases DOI 10.1016/j.ard.2025.05.020 YÖKSİS SJR Q1 JCR Q1
  2. 2025 Validation of Axial Juvenile Spondyloarthropathy Criteria in Turkish Juvenile Spondyloarthropathy Patients Diagnostics DOI 10.3390/diagnostics15121498 YÖKSİS SJR Q2 JCR Q1
  3. 2025 A challenging case of limb autoamputation Rheumatology DOI 10.1093/rheumatology/keaf044 YÖKSİS SJR Q1 JCR Q1
  4. 2025 Predictive role of muscle MRI in juvenile dermatomyositis: A tertiary center experience European Journal of Radiology DOI 10.1016/j.ejrad.2025.112599 YÖKSİS SJR Q1 JCR Q1
  5. 2025 EULAR/PReS endorsed recommendations for the management of familial Mediterranean fever (FMF): 2024 update Annals of the Rheumatic Diseases DOI 10.1016/j.ard.2025.01.028 YÖKSİS SJR Q1 JCR Q1
  6. 2025 Transcriptome analysis of unmedicated heterozygous familial Mediterranean fever patients reveals a type I interferon signature driving increasing Pyrin expression Annals of the Rheumatic Diseases DOI 10.1016/j.ard.2025.08.001 YÖKSİS SJR Q1 JCR Q1
  7. 2025 Familial Mediterranean Fever; Recent Advances, Future Prospectives Diagnostics DOI 10.3390/diagnostics15070813 YÖKSİS SJR Q2 JCR Q1
  8. 2025 Treatment responses and relapse predictors in pediatric CNO: insights from a referral center Rheumatology DOI 10.1093/rheumatology/keaf645 YÖKSİS SJR Q1 JCR Q1
  9. 2025 Validation of the EULAR/ACR classification criteria for chronic nonbacterial osteomyelitis in a pediatric cohort Clinical Rheumatology DOI 10.1007/s10067-025-07653-z YÖKSİS SJR Q2 JCR Q3
  10. 2025 Safety of colchicine on fertility, pregnancy, and lactation: a systematic review and meta-analysis informing the EULAR/PReS recommendations for familial Mediterranean fever Annals of the Rheumatic Diseases DOI 10.1016/j.ard.2025.02.005 YÖKSİS SJR Q1 JCR Q1
  11. 2025 Microbial dysbiosis fuels STING-driven autoinflammation through cyclic dinucleotides Journal of Autoimmunity DOI 10.1016/j.jaut.2025.103434 YÖKSİS SJR Q1 JCR Q1
  12. 2025 Lack of HLH in FMF Pediatric Rheumatology DOI 10.1186/s12969-025-01064-9 YÖKSİS SJR Q1 JCR Q2
  13. 2025 Cord blood chemokine levels as a predictor of oxidative stress and morbidities of prematurity Cytokine DOI 10.1016/j.cyto.2025.157006 YÖKSİS SJR Q1 JCR Q2
  14. 2025 Phenotypic subgroups and classification criteria performance in pediatric Behçet’s disease: ınsights on systemic ınvolvement Rheumatology DOI 10.1093/rheumatology/keaf637 YÖKSİS SJR Q1 JCR Q1
  15. 2025 Polyarticular juvenile idiopathic arthritis has a distinct co-inhibitor receptor profile Rheumatology DOI 10.1093/rheumatology/keae306 YÖKSİS SJR Q1 JCR Q1
  16. 2025 A case with systemic juvenile idiopathic arthritis treated with tofacitinib and rapamycin Rheumatology DOI 10.1093/rheumatology/keae637 YÖKSİS SJR Q1 JCR Q1
  17. 2025 Re-evaluation of MEFV carriers previously diagnosed with FMF: a colchicine discontinuation study Rheumatology DOI 10.1093/rheumatology/keaf340 YÖKSİS SJR Q1 JCR Q1
  18. 2024 Detection of genetic mutations underlying early-onset systemic lupus erythematosus LUPUS DOI 10.1177/09612033241255011 YÖKSİS SJR Q2 JCR Q3
  19. 2024 The risk of cardiovascular comorbidity in children with Behçet’s disease Rheumatology DOI 10.1093/rheumatology/kead505 YÖKSİS SJR Q1 JCR Q1
  20. 2024 5,6-dimethylxanthenone-4-acetic acid (DMXAA), a partial STING agonist, competes for human STING activation Frontiers in Immunology DOI 10.3389/fimmu.2024.1353336 YÖKSİS SJR Q1 JCR Q1

Akademisyenlere dön